KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

Item

http://www.wikidata.org/entity/Q21245466

description

2009 nî lūn-bûn

@nan

2009 թուականին հրատարակուած գիտական յօդուած

@hyw

2009 թվականին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@ast

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en-gb

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@nl

type

Item

label

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@ast

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en-gb

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@nl

prefLabel

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@ast

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en-gb

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@nl

P1476

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

@en

P2093

Ayesha B Alvero

http://www.w3.org/2001/XMLSchema#string

Gil Mor

http://www.w3.org/2001/XMLSchema#string

Ki Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Richard Woessner

http://www.w3.org/2001/XMLSchema#string

Yanhua Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo

Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8

Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells

Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

Autocrine and paracrine regulation by cytokines and growth factors in melanoma.

Antitumor activity of a kinesin inhibitor.

Current diagnosis and treatment modalities for ovarian cancer.

The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

P2888

1479-5876-7-63

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-7-63

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ewan M. Tytler

P577

2009-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26683049

http://www.w3.org/2001/XMLSchema#string

P6179

1050875235

http://www.w3.org/2001/XMLSchema#string

P698

19619321

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

2719595

http://www.w3.org/2001/XMLSchema#string